Skin & Hair: Collagen, GHK-Cu and Pigmentation Data

5 September 2026 · 10 min read

Thymosin Beta-4 and TB-500: What Is Established, and What Is Simply Assumed

TB-500 is routinely described as the healing peptide for tendons and muscle. It is a fragment of a naturally occurring protein with a real preclinical literature — and a human evidence base that stops well short of the claims.

TB-500

5 September 2026 · 9 min read

GHK-Cu: What the Copper Peptide Research Supports, and Where It Stops

GHK-Cu is the copper peptide behind a large part of the peptide skincare category. The laboratory and gene-expression literature is substantial; the controlled clinical literature in humans is much thinner than the marketing suggests.

GHK-Cu

31 August 2026 · 6 min read

Investigational Peptides and Nociceptive Pathways: A Desk Review of Preclinical Candidates

An editorial evaluation of preclinical peptide compounds targeting inflammatory signaling, tissue regeneration, and neuropathic pathways in chronic pain research.

BPC-157 · TB-500

31 August 2026 · 6 min read

Dissecting Consumer Biometric Telemetry: Signal, Noise, and Protocol Context

A critical examination of wearable sensor metrics, evaluating the fidelity of heart rate variability, skin temperature, and sleep staging against clinical standards in performance monitoring.

Creatine

31 August 2026 · 5 min read

Evaluating Multi-Peptide Tissue Remodeling: A Critical Analysis of the 'GLOW' Triad

An editorial assessment of the combined biological pathways of GHK-Cu, BPC-157, and TB-500 in preclinical models of extracellular matrix repair and microvascular restoration.

BPC-157 · TB-500 · GHK-Cu

31 August 2026 · 6 min read

Thymosin Beta-4 Fragments in Preclinical Research: An Analytical Review of TB-500 Methodologies

An examination of Thymosin Beta-4 derivatives in cell and animal models, detailing actin dynamics, angiogenic pathways, and technical standards for laboratory reproducibility.

TB-500

31 August 2026 · 5 min read

Deconstructing the KLOW Protocol: An Analytical Desk Review of Multi-Peptide Stacking

A rigorous examination of the speculative KLOW protocol, evaluating preclinical evidence for KPV, LL-37, BPC-157, and GHK-Cu against regulatory standards, athletic anti-doping rules, and analytical safety.

BPC-157 · GHK-Cu

31 August 2026 · 6 min read

Beyond the Celebrity Spotlight: A Scientific Evaluation of Peptide Signaling and Dermal Remodeling

A critical, evidence-first assessment of injectable, topical, and oral peptide modalities popularized in mainstream anti-aging discussions, evaluating their pharmacokinetic realities and cellular mechanisms.

GHK-Cu · Ipamorelin · CJC-1295 · Sermorelin

31 August 2026 · 5 min read

Deciphering GHK-Cu: A Retrospective on Extracellular Remodeling and Tissue Biology

First isolated in 1973, the tripeptide-copper complex GHK-Cu remains a central candidate in extracellular matrix research, dermal turnover, and tissue regeneration models.

GHK-Cu

31 August 2026 · 6 min read

KPV in Preclinical Anti-Inflammatory Research: Mechanistic Insights and Mucosal Signaling

An investigation into Lysine-Proline-Valine (KPV), an alpha-MSH-derived tripeptide. We analyze its molecular targets, NF-κB modulation, and application in gut and cutaneous model systems.

31 August 2026 · 5 min read

BPC-157 in 2026: Evaluating the Preclinical Evidence, Regulatory Position, and the Human Data Gap

An editorial review of Body Protection Compound-157, examining preclinical tissue repair mechanisms, the absence of robust human trial data, anti-doping prohibitions, and evolving regulatory classifications.

BPC-157

31 August 2026 · 6 min read

Evaluating BPC-157: Preclinical Mechanisms, Gastrointestinal Origins, and the Clinical Evidence Gap

An analytical review of Body Protection Compound-157, examining its proposed angiogenic pathways, connective tissue research models, and the significant divide between rodent studies and preclinical literature versus human clinical trials.

BPC-157

31 August 2026 · 4 min read

Evaluating Ipamorelin: Selectivity, Endocrine Dynamics, and Preclinical Evidence

An editorial analysis of ipamorelin, examining its ghrelin-receptor selectivity, pulsatile growth hormone secretagogue profile, preclinical data on bone and gut motility, and key analytical considerations for research environments.

Ipamorelin · Growth hormone

24 August 2026 · 10 min read

Cold Chain, Freeze-Thaw and What Actually Degrades a Peptide

Lyophilised peptides are more robust than the shipping rhetoric suggests, and reconstituted ones are more fragile. What the degradation chemistry says about transport, storage and the freezer door.

TB-500 · GHK-Cu